Engineered heterodimeric protein domains

Details for Australian Patent Application No. 2007229698 (hide)

Owner Merck Patent GmbH

Inventors Davis, Jonathan H.; Huston, James Stafford

Agent Davies Collison Cave

Pub. Number AU-B-2007229698

PCT Pub. Number WO2007/110205

Priority 60/785,474 24.03.06 US

Filing date 23 March 2007

Wipo publication date 4 October 2007

Acceptance publication date 4 October 2012

International Classifications

C07K 16/46 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12N 15/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

13 November 2008 PCT application entered the National Phase

  PCT publication WO2007/110205 Priority application(s): WO2007/110205

4 October 2012 Application Accepted

  Published as AU-B-2007229698

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007229708-Imidazopyridin-2-one derivatives as inhibitors of endothelial lipase

2007229688-Occlusion instrument and method for its production